Intended for healthcare professionals

Letters Non-alcoholic fatty liver disease and cardiovascular risk

Authors’ reply to McKenna-Barry and Ryan

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6549 (Published 22 November 2019) Cite this as: BMJ 2019;367:l6549
  1. Naveed Sattar, professor of metabolic medicine1,
  2. William Alazawi, reader in hepatology2
  3. on behalf of coauthors
  1. 1Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK
  2. 2Barts Liver Centre, Blizard Institute, Queen Mary, University of London, London, UK
  1. naveed.sattar{at}glasgow.ac.uk
  2. w.alazawi{at}qmul.ac.uk

We thank McKenna-Barry and Ryan for their interest in our article on non-alcoholic fatty liver disease and cardiovascular risk.12 Although studies have reported associations between stage of liver disease and surrogate markers of cardiovascular disease, we agree that more work is needed to examine whether the existence or stage of non-alcoholic steatohepatitis is a meaningful independent risk factor for …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription